Navigation Links
Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth
Date:7/31/2013

DUBLIN, Ireland, July 31, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/59zgn7/diabetes) has announced the addition of the "Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth" report to their offering.

Insights into the diabetes epidemiology, cost of therapy, research and development pipeline and the promising molecules which are anticipated to be launched by 2018 are discussed in the report. The report provides an in-depth analysis type 1 and type 2 diabetes. The report provides an in-depth analysis on oral anti-diabetics agents, insulin products and drivers and barriers that could significantly impact the overall anti-diabetes market during the forecast period. Additionally, it explores the competitive landscape, including benchmarking the top companies in the market and the key issues and trends that are likely to have an impact on the Indian diabetes market during the forecast period. Finally, a key trend analysis for mergers and acquisitions and licensing agreements involving diabetes therapies is also discussed in the report.

This analysis revealed that the overall anti-diabetes market in India was worth $680.3m in 2011 and is projected to grow at a CAGR of 11.3% between 2011 and 2018 to reach $1,446m in 2018. High and growing diabetes population in the country, rising obese and geriatric population, and rapid market adoption of drugs from the classes such as Dipeptidyl Peptidase 4 (DPP-4) inhibitors, Glucagon-Like Peptide (GLP)-1, Sodium-Glucose Transport Proteins (SGLT-1) and others would drive the anti-diabetes market in the forecast period.

The R&D product pipeline for DM, dominated by
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014  ConvaTec, a privately-held medical products and ... appointed Interim Chief Executive Officer of the company, effective ... Ken Berger .  "The Board of Directors of ConvaTec ... over the past three years," said Magnus Lundberg ... are confident that the company is well positioned for ...
(Date:12/22/2014)... 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... the following open letter to shareholders from President ... Sc. Dear RXi Shareholders, ... inaccurate statements posted on certain social media sites ...
(Date:12/22/2014)... , Dec. 22, 2014  Pfenex Inc. (NYSE ... recombinant anthrax vaccine, has been filed and is now ... provided by the Department of Health and Human Services ... (BARDA). "We are extremely pleased to have ... Px563L.  This represents a significant milestone in our company,s ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3
... September 30 Gamida Cell announced,today the publication of ... widely known as "StemEx", as a therapy for blood ... ex vivo expanded,umbilical cord blood cell graft for allogeneic ... Petropoulos, will be published in the,November 2009 issue of ...
... 30 GenVec, Inc. (Nasdaq: GNVC ) announced today ... and Research (SBIR) grant from the National Cancer Institute (NCI) ... research of a new approach to treating metastatic cancer. Under ... hypothesis that the delivery of a specific gene will stimulate ...
Cached Medicine Technology:Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 3GenVec Receives National Cancer Institute Grant to Expand Cancer Program 2
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... Yunx.co.uk, a hot style dress supplier that offers all ... unveils 65 new bridesmaid dresses and announces ... to 80% off. , Yunx.co.uk’s dresses are very popular ... looks and delicate craftsmanship. These new bridesmaid dresses are ... and offering high-quality women’s dresses with fast delivery to ...
(Date:12/24/2014)... a famous bamboo flooring company offering bamboo flooring products ... its multiple layer bamboo panel board collection , and ... Bamboo panel is the product made from 100 percent ... features high quality selective bamboo and eco-friendly adhesives that ... consists of multiple layers of bamboo. , According to ...
(Date:12/24/2014)... infection does not contribute to mental decline in people with ... made it possible for people with HIV to survive much ... and other types of mental impairment as they age, the ... other viruses -- a common problem in people with HIV ... has been the hepatitis C virus, which infects about one ...
(Date:12/24/2014)... (HealthDay News) -- Researchers say they have used human ... eggs and sperm. While this had already been ... time that these types of cells -- called primordial ... stem cells, according to the team at the University ... germ cells is one of the earliest events during ...
Breaking Medicine News(10 mins):Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2
... protective effect , SUNDAY, April 18 (HealthDay News) -- ... seem to have a reduced risk of developing breast ... the study, which is to be presented Sunday at ... Washington, D.C., did not separate out which specific vitamins ...
... from a sentinel lymph node removed during surgery is a ... false negatives, which means the node, when analyzed under a ... occur in the patient. The sentinel node is the first ... Now, researchers from Georgetown Lombardi Comprehensive Center say that they ...
... ... has successfully completed deployment of CellTrak workflow automation and visit compliance solutions. The ... , ... April 18, 2010 -- ABC Hospice, Inc, a premier hospice provider in North East ...
... ... , ... (PRWEB) April 18, 2010 -- Allegheny Medical Integrated Health Services ( http://www.alleghenymedical.com/ ), one ... professionals whose mission is to build better health for every aspect of an individual,s ...
... life than in past generations, study finds , FRIDAY, April ... an earlier age and failing to lose the extra pounds ... expectancy will be worse than previously estimated. , The ... 1966 and 1985 became obese -- a step above merely ...
... ... Orthopedics is donating 300 seedlings for Westminster’s Arbor Day and Earth Day Celebration Saturday, April ... Golden, CO (PRWEB) ... with the City of Westminster to celebrate Earth Day and Arbor Day April 17. As ...
Cached Medicine News:Health News:Supplements Might Reduce Breast Cancer Risk 2Health News:Supplements Might Reduce Breast Cancer Risk 3Health News:Routine breast cancer biopsy might predict lymph node cancer spread 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 3Health News:Allegheny Medical's Occupational Health Services Helps Employers Build a Healthier Workforce 2Health News:Allegheny Medical's Occupational Health Services Helps Employers Build a Healthier Workforce 3Health News:Obesity Epidemic May Cut Life Spans of Young Adults 2Health News:Panorama Orthopedics and the City of Westminster Join Forces to Improve the Environment through Tree Giveaway 2
... This Sarmiento style Patella-Tendon-Bearing brace is designed ... the tibia and fibula. The tibial crest ... intra medullary nailing and removal of internal ... movement of joints above and below the ...
Designed as an excellent form of primary suspension...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... This lightweight orthosis is designed to ... joint while allowing unobstructed motion of ... more custom fit the splint may ... formed using a heat gun. One ...
Medicine Products: